Probiotics and human lactational mastitis: A scoping review |
| |
| Institution: | 1. Rosemary Bryant AO Research Centre, Division of Health Sciences, University of South Australia, Adelaide, South Australia;2. Adelaide Nursing School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia;3. The Centre for Evidence-based Practice South Australia (CEPSA): a Joanna Briggs Institute Centre of Excellence, Adelaide, Australia;4. The Women’s and Children’s Hospital, North Adelaide, Australia;5. Clinical and Health Sciences, University of South Australia, Adelaide, South Australia;1. Centre of Research Excellence in Stillbirth, Mater Research Institute, The University of Queensland, Brisbane, Australia;2. Sydney Institute of Women, Children and their Families, Sydney Local Health District, NSW Australia;3. Charles Perkins Centre, University of Sydney, NSW, Australia;4. Prevention Research Collaboration, Sydney School of Public Health, University of Sydney, Australia;5. Red Nose Australia;6. SANDS Australia;7. Stillbirth Foundation Australia;8. Still Aware;9. SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, Australia;1. Charles Darwin University, Australia;2. Charles Darwin University & Edith Cowan University, Australia;3. Politeknik Kesehatan Kartini, Bali, Indonesia;4. Politeknik Kesehatan Kemenkes Denpasar, Indonesia;1. Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan;2. Department of Clinical Neurophysiology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan;1. Department of Obstetrics and Gynecology, Jichi Medical University, Tochigi, Japan |
| |
| Abstract: | ProblemLactational mastitis is a common condition amongst breastfeeding women. It is associated with decreased breastfeeding rates and often treated with antibiotics.BackgroundThe anti-inflammatory effects of probiotics have been identified as a potential treatment or prevention strategy for lactational mastitis leading to increased commercial and public interest. Despite the marketing of probiotics to women, evidence is still emerging as to its efficacy.Aim/MethodsThis scoping review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) to identify and examine the evidence around probiotic consumption and lactational mastitis. The review addressed the question; what is the evidence regarding probiotic consumption and human lactational mastitis? Studies were critically appraised using the Joanna Briggs Institute checklist for randomised control trials (RCTs).FindingsFive RCTs met the inclusion criteria; three concerned probiotic consumption for the treatment of mastitis, two for the prevention of mastitis. All reported a lower incidence of mastitis in the probiotic groups.DiscussionAlthough potentially promising results were reported across all studies there were significant methodological limitations concerning; appropriately described baseline characteristics, study hypotheses, lack of power calculations, definitional issues, and potential conflicts of interest.ConclusionProbiotics may have utility for the treatment or prevention of lactational mastitis. However only a few studies with significant limitations have been published to date. Well designed and conducted studies are needed before evidence-based recommendations can be made for use of probiotics in the treatment or prevention of lactational mastitis. |
| |
| Keywords: | Microbiota Breast milk Breast feeding Lactobacillus Maternity care |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
